PROVIDER PROFILE · NPI 1932177847

Jane BorkowskiMD

Hematology-OncologyKirkland, WAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

303

Unique beneficiaries

—

Total services

754

Distinct HCPCS

Medicare payment

$50K

Peer benchmark

Total Medicare services vs. 247 Hematology-Oncology providers in WA — above median (cohort median 770).

PRESCRIBING · PART D · 2024

Total Rx claims

479

Beneficiaries

—

Total drug cost

$520K

Distinct drugs

Brand share

19.6%

Top prescribed drugs

Anastrozole138 claims

Lidocaine/Prilocaine34 claims

Prochlorperazine Maleate32 claims

Dexamethasone32 claims

Tamoxifen Citrate30 claims

QUALITY · MIPS · 2024

Final MIPS score

93.8

Quality

74.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.79%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$107

Payment records

By payment type

Food and Beverage$107

REFERRAL NETWORK

Where Jane Borkowski's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
KING COUNTY PUBLIC HOSPITAL DISTRICT NO. 2	137	4,491
FRED HUTCHINSON CANCER CENTER	137	5,917
Maria Chong Diagnostic Radiology · Lynnwood, WA	34	360
Aimee Kohn Medical Oncology · Portland, OR	16	158
Michele Frank Hematology · Kirkland, WA	13	632
Kara Carlson Diagnostic Radiology · Lynnwood, WA	11	35

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history